Skip to main content

Step Count Inversely Linked to All-Cause, Cardiovascular Mortality

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 10, 2023 -- There is a significant inverse association between daily step count and all-cause and cardiovascular (CV) mortality, according to a review published online Aug. 8 in the European Journal of Preventive Cardiology.

Maciej Banach, M.D., Ph.D., from the Medical University of Lodz in Poland, and colleagues conducted a systematic review to examine the association between step count and all-cause mortality and CV mortality. The meta-analysis included data from 17 cohort studies with 226,889 participants with a median follow-up of 7.1 years.

The researchers found that a 1,000-step increment was associated with a significantly reduced risk for all-cause mortality (hazard ratio, 0.85) and a 500-step increment was associated with a decrease in CV mortality (hazard ratio, 0.93). Quartiles 1, 2, and 3 with a median of 5,537; 7,370; and 11,529 steps, respectively, compared with the reference quartile with a median of 3,967 steps/day, were associated with a lower risk for all-cause mortality (47, 55, and 67 percent, respectively). Compared with the lowest quartile steps/day (median 2,337), there was a linear association seen for higher quartiles of steps/day (3,982; 6,661; and 10,413, respectively) with a reduced risk for CV mortality (16, 49, and 77 percent, respectively). A nonlinear dose-response association was seen between step count and all-cause and CV mortality using a restricted splines model, with a progressively lower mortality risk seen with increased step count.

"Our results may be used to promote public awareness of the importance of physical activity, particularly in the easily implementable activity of walking," the authors write.

Several authors disclosed ties to the pharmaceutical and technology industries.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older

TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.